727 related articles for article (PubMed ID: 19448065)
21. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
Chagpar A; Middleton LP; Sahin AA; Meric-Bernstam F; Kuerer HM; Feig BW; Ross MI; Ames FC; Singletary SE; Buchholz TA; Valero V; Hunt KK
Cancer; 2005 Apr; 103(8):1581-6. PubMed ID: 15747375
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
23. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
24. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases.
Boler DE; Uras C; Ince U; Cabioglu N
Breast; 2012 Aug; 21(4):518-23. PubMed ID: 22410110
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
[TBL] [Abstract][Full Text] [Related]
26. High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer.
Hirche C; Mohr Z; Kneif S; Murawa D; Hünerbein M
J Surg Oncol; 2012 Feb; 105(2):162-6. PubMed ID: 21882198
[TBL] [Abstract][Full Text] [Related]
27. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.
Saha S; Ali S; Ghanem M; Soni M; Wiese D; Arora M; Singh T; Iddings D
Ann Surg Oncol; 2009 Feb; 16(2):276-80. PubMed ID: 19050967
[TBL] [Abstract][Full Text] [Related]
29. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
[TBL] [Abstract][Full Text] [Related]
30. The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer.
Fan YG; Tan YY; Wu CT; Treseler P; Lu Y; Chan CW; Hwang S; Ewing C; Esserman L; Morita E; Leong SP
Ann Surg Oncol; 2005 Sep; 12(9):705-11. PubMed ID: 16079953
[TBL] [Abstract][Full Text] [Related]
31. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
[TBL] [Abstract][Full Text] [Related]
32. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
34. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
35. Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer.
Pugliese MS; Karam AK; Hsu M; Stempel MM; Patil SM; Ho AY; Traina TA; Van Zee KJ; Cody HS; Morrow M; Gemignani ML
Ann Surg Oncol; 2010 Apr; 17(4):1063-8. PubMed ID: 20033325
[TBL] [Abstract][Full Text] [Related]
36. Histopathologic analysis of sentinel lymph nodes in breast carcinoma.
Hsieh PP; Ho WL; Yeh DC; Liu TJ; Wu CC; Lin JH; Wang SJ
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):744-50. PubMed ID: 11076431
[TBL] [Abstract][Full Text] [Related]
37. Predicting axillary sentinel node status in patients with primary breast cancer.
Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
[TBL] [Abstract][Full Text] [Related]
38. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
39. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
Davit FE; Gatmaitan P; Garguilo G
Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
[TBL] [Abstract][Full Text] [Related]
40. Predicting sentinel lymph node metastases in infiltrating breast carcinoma with vascular invasion.
Jonjic N; Mustac E; Dekanic A; Marijic B; Gaspar B; Kolic I; Coklo M; Sasso F
Int J Surg Pathol; 2006 Oct; 14(4):306-11. PubMed ID: 17041193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
